MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on every 2026 New York Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in New York cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Multiple sclerosis drugs by 2026 New York Part D plan
DrugHealthSpring Assurance Rx$35.70/moS5617-013Wellcare Value Script$42.40/moS4802-138Wellcare Classic$45.70/moS4802-077HealthSpring Extra Rx$91.60/moS5617-353AARP Medicare Rx Saver from UHC$105.80/moS5921-379SilverScript Choice$116.00/moS5601-006Humana Basic Rx Plan$140.90/moS5884-216Humana Value Rx Plan$158.90/moS5884-218AARP Medicare Rx Preferred from UHC$163.70/moS5921-382Humana Premier Rx Plan$173.60/moS5884-217
KesimptaofatumumabTier 5PA25%QL 1.6/28dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
teriflunomidegeneric AubagioTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dNot coveredNot coveredTier 5PA25%QL 30/30dTier 4PA30%QL 30/30dTier 4PA31%QL 30/30dTier 428%QL 30/30dTier 4PA50%QL 30/30d
dimethyl fumarategeneric TecfideraTier 4PA29%QL 14/30dTier 4PA40%QL 56/28dTier 4PA28%QL 56/28dTier 4PA29%QL 14/30dTier 438%QL 56/28dNot coveredNot coveredNot coveredTier 428%QL 56/28dTier 4PA50%QL 14/30d
Vumeritydiroximel fumarateNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
fingolimodgeneric GilenyaNot coveredTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dNot coveredTier 438%QL 30/30dTier 5PA25%QL 30/30dTier 3PA25%QL 30/30dTier 3PA17%QL 30/30dTier 428%QL 30/30dTier 3PA$45.00QL 30/30d
MayzentsiponimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ZeposiaozanimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
MavencladcladribineNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.